Matches in Wikidata for { <http://www.wikidata.org/entity/Q64658095> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64658095 description "clinical trial" @default.
- Q64658095 description "ensayu clínicu" @default.
- Q64658095 description "klinisch onderzoek" @default.
- Q64658095 description "клінічне випробування" @default.
- Q64658095 name "A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4" @default.
- Q64658095 type Item @default.
- Q64658095 label "A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4" @default.
- Q64658095 prefLabel "A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4" @default.
- Q64658095 P1050 Q64658095-292A6EB6-4A1F-4DD1-B7DB-316936B25890 @default.
- Q64658095 P1050 Q64658095-70D52220-AD29-48CA-95B2-9C63B2B3840E @default.
- Q64658095 P1050 Q64658095-B9A47B62-305E-4909-8870-AACBB68FC94B @default.
- Q64658095 P1132 Q64658095-35AA571F-61D3-4A1C-82A8-D90E7DDF1728 @default.
- Q64658095 P1476 Q64658095-39E02F01-A403-43D6-AE00-E26FAC7FDBFD @default.
- Q64658095 P17 Q64658095-A44D3766-01A7-4714-8E69-1832C99AC24B @default.
- Q64658095 P17 Q64658095-CC47A9C3-4D6A-456D-BB9D-9F0E1FEBEC10 @default.
- Q64658095 P2899 Q64658095-91E98FB9-220E-4B80-92CA-F0A46FC57A43 @default.
- Q64658095 P3098 Q64658095-796823EA-951A-4A0C-8C46-0870CAFC0D60 @default.
- Q64658095 P31 Q64658095-1991204F-77AD-4BAD-90B3-55B3F6FC9877 @default.
- Q64658095 P4135 Q64658095-62C9F8BF-C355-452B-A934-6D658ABEDE20 @default.
- Q64658095 P4844 Q64658095-DC86A2F1-AFAB-47D4-A4DB-5BAC6535923F @default.
- Q64658095 P580 Q64658095-596C60A9-4772-4981-8485-1E54EE48503E @default.
- Q64658095 P582 Q64658095-935A39C3-DBB3-469B-891D-C438617526E9 @default.
- Q64658095 P6099 Q64658095-7D0671BB-DF83-477A-A5EF-294CE6CED9CD @default.
- Q64658095 P8363 Q64658095-784F1E4C-ED28-493A-BC15-CAE84CEF7C68 @default.
- Q64658095 P859 Q64658095-4AD8932D-DD1D-46AE-86FA-A24045A46F3F @default.
- Q64658095 P1050 Q131742 @default.
- Q64658095 P1050 Q154869 @default.
- Q64658095 P1050 Q157661 @default.
- Q64658095 P1132 "+168" @default.
- Q64658095 P1476 "A Randomized, Double-blinded, Multicenter Study to Evaluate the Antiviral Efficacy and Safety of Adding the HCV Polymerase Inhibitor Prodrug (RO5024048) for 24 Weeks to the Currently Approved Combination of Pegasys® and Copegus® in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 or 4" @default.
- Q64658095 P17 Q16 @default.
- Q64658095 P17 Q30 @default.
- Q64658095 P2899 "+18" @default.
- Q64658095 P3098 "NCT01057667" @default.
- Q64658095 P31 Q30612 @default.
- Q64658095 P4135 "+70" @default.
- Q64658095 P4844 Q20817235 @default.
- Q64658095 P580 "2010-02-01T00:00:00Z" @default.
- Q64658095 P582 "2012-04-01T00:00:00Z" @default.
- Q64658095 P6099 Q42824440 @default.
- Q64658095 P8363 Q78089383 @default.
- Q64658095 P859 Q212646 @default.